Berenson Stephen 4
4 · Seres Therapeutics, Inc. · Filed Jul 3, 2024
Insider Transaction Report
Form 4
Berenson Stephen
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-07-01+114,782→ 114,782 totalExercise: $0.72Exp: 2034-06-30→ Common Stock (114,782 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in four equal quarterly installments occurring on October 1, 2024, January 1, 2025, April 1, 2025 and July 1, 2025, provided that if the Company's 2025 annual meeting of stockholders occurs before July 1, 2025, the final quarterly vesting installment will vest on the day immediately prior to the date of such annual meeting, in each case, subject to the reporting person continuing in service on the Board as a non-employee director through the applicable vesting date.